AR117535A1 - USEFUL POLYPEPTIDES FOR EDITING GENES AND METHODS OF USE - Google Patents

USEFUL POLYPEPTIDES FOR EDITING GENES AND METHODS OF USE

Info

Publication number
AR117535A1
AR117535A1 ARP190103890A ARP190103890A AR117535A1 AR 117535 A1 AR117535 A1 AR 117535A1 AR P190103890 A ARP190103890 A AR P190103890A AR P190103890 A ARP190103890 A AR P190103890A AR 117535 A1 AR117535 A1 AR 117535A1
Authority
AR
Argentina
Prior art keywords
interest
rna
target sequence
compositions
methods
Prior art date
Application number
ARP190103890A
Other languages
Spanish (es)
Inventor
Michael Lassner
Rodolph Barrangou
Mark Moore
Tedd D Elich
Alexandra Briner Crawley
Tyson D Bowen
Original Assignee
Lifeedit Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lifeedit Inc filed Critical Lifeedit Inc
Publication of AR117535A1 publication Critical patent/AR117535A1/en

Links

Landscapes

  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Se proporcionan composiciones y métodos de unión con una secuencia diana de interés. Las composiciones incluyen proteínas de fusión entre proteínas de unión a ADN o dominios de proteína y proteínas que modifican ácidos nucleicos o dominios de proteínas. Las composiciones se usan en la escisión o la modificación de una secuencia diana de interés, visualización de una secuencia diana de interés y la modificación de la expresión de una secuencia de interés. Las composiciones comprenden polipéptidos de nucleasa guiados por ARN, ARN de CRISPR, ARN de CRISPR transactivantes, ARN de guía, desaminasas y moléculas de ácido nucleico que los codifican. También se proporcionan vectores y células huésped que comprenden las moléculas de ácido nucleico. También se proporcionan sistema de CRISPR para unir una secuencia diana de interés, en donde el sistema de CRISPR comprende un polipéptido de nucleasa guiado por ARN y uno o más ARN de guía. También se proporcionan desaminasas que se pueden fusionar con un polipéptido de unión a ADN y también pueden ser de utilidad para la edición de genes.Compositions and methods of binding with a target sequence of interest are provided. The compositions include fusion proteins between DNA-binding proteins or protein domains and proteins that modify nucleic acids or protein domains. The compositions are used in the cleavage or modification of a target sequence of interest, visualization of a target sequence of interest, and modification of the expression of a sequence of interest. The compositions comprise RNA-guided nuclease polypeptides, CRISPR RNA, transactivating CRISPR RNA, guide RNA, deaminases, and nucleic acid molecules that encode them. Vectors and host cells comprising the nucleic acid molecules are also provided. Also provided are CRISPR system for linking a target sequence of interest, wherein the CRISPR system comprises an RNA-guided nuclease polypeptide and one or more guide RNAs. Also provided are deaminases that can be fused to a DNA-binding polypeptide and can also be useful for gene editing.

ARP190103890A 2018-12-27 2019-12-26 USEFUL POLYPEPTIDES FOR EDITING GENES AND METHODS OF USE AR117535A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201862785391P 2018-12-27 2018-12-27

Publications (1)

Publication Number Publication Date
AR117535A1 true AR117535A1 (en) 2021-08-11

Family

ID=77568212

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP190103890A AR117535A1 (en) 2018-12-27 2019-12-26 USEFUL POLYPEPTIDES FOR EDITING GENES AND METHODS OF USE

Country Status (1)

Country Link
AR (1) AR117535A1 (en)

Similar Documents

Publication Publication Date Title
ES2970169T3 (en) Useful polypeptides for gene editing and methods of use
MX2020013124A (en) Rna-guided nucleases and active fragments and variants thereof and methods of use.
CL2021002741A1 (en) A prevotella and francisella crispr protein 1 (cpf1) isolated from lachnospiraceae bacterium nd2006; fusion protein comprising it; nucleic acid; vector; methods for altering the genome of a cell or a double-stranded DNA molecule in vitro using such proteins (divisional de sol. 201903004)
WO2019139645A3 (en) High efficiency base editors comprising gam
PH12020551039A1 (en) Non-viral dna vectors and uses thereof for antibody and fusion protein production
WO2017070632A3 (en) Nucleobase editors and uses thereof
MX2022001849A (en) Rna-guided nucleases and active fragments and variants thereof and methods of use.
GB2569733A (en) RNA-guided nucleic acid modifying enzymes and methods of use thereof
WO2022056254A3 (en) Dna modifying enzymes and active fragments and variants thereof and methods of use
ES2690386T3 (en) Composition for cleaving a target DNA comprising a specific guide RNA for the target DNA and the nucleic acid encoding the Cas protein or the Cas protein itself, and its uses
MX2019002498A (en) Methods and products for expressing proteins in cells.
PE20181275A1 (en) CHEMERICAL POLYPEPTIDE ASSEMBLY AND METHODS FOR MAKING AND USING THE SAME
HRP20240408T1 (en) Ultra-long acting insulin-fc fusion proteins and methods of use
AR086476A2 (en) METHODS OF PRODUCTION OF A PROTEIN OF INTEREST HETEROLOGY IN A CELL, TO INCREASE THE SPECIFIC CELLULAR PRODUCTIVITY OF A PROTEIN OF MEMBRANE INTEREST OR SECRETED IN A CELL, TO INCREASE THE EFFECTIVENESS OF TRANSFECTION OF A CELL THAT EXPRESSES A PROTEIN OF INTEREST SECRETED IN A CELL AND TO IDENTIFY A PROTEIN FUNCTION MODULATOR WITH START DOMAIN, EXPRESSION VECTORS, CELLS, PROTEINS, PHARMACEUTICAL COMPOSITIONS AND ITS USES
Brees et al. A cost-effective approach to microporate mammalian cells with the Neon Transfection System
WO2019084362A3 (en) Fusion protein and nucleic acid molecule for exogenous stimulant-dependent stress granule assembly
AR051837A1 (en) PRODUCTION OF RECOMBINANT FUSION PROTEINS WITHIN SIMILAR ASSEMBLIES TO RECOMBINANT PROTEIN BODIES (ESCPR)
BR112022021459A2 (en) RNA-GUIDED NUCLEASES, ACTIVE FRAGMENTS AND VARIANTS THEREOF, AND METHODS OF USE
EA202190267A1 (en) METHODS AND COMPOSITIONS USING RECOMBINANT DENDRITIC CELLS FOR CANCER THERAPY
BR112021007503A2 (en) Fusion protein, nucleic acid molecule, method for editing genetic material, and, systems for editing genetic material and for delivering genome editing components
AR117535A1 (en) USEFUL POLYPEPTIDES FOR EDITING GENES AND METHODS OF USE
WO2020006131A3 (en) Nucleases for genome editing
EA202191788A1 (en) POLYPEPTIDES USED FOR GENE EDITING AND METHODS OF THEIR APPLICATION
AR115486A1 (en) RNA-GUIDED NUCLEASES AND THEIR ACTIVE FRAGMENTS AND VARIANTS AND METHODS OF USE
AR120928A1 (en) RNA-GUIDED NUCLEASES AND THEIR ACTIVE FRAGMENTS AND VARIANTS AND METHODS OF USE